Latka logo
BiVACOR logo

BiVACORrevenue

Houston, TexasFounded 2008CEO Jim Dillon

BiVACOR® is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure, including the development of the world's first titanium Total Artificial Heart (TAH).

bivacor.comLinkedInUpdated Sep 10, 2026
Annual revenue
$18.6M
Sep 2025EST
Employees
57
Sep 2025

BiVACOR revenue

BiVACOR has not published its revenue. Growjo puts it at about $18.6M a year (September 2025).

$0
$5M
$10M
$15M
$0
–
$18.6M
20082009–242025
ReportedEstimateFounded 2008 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$18.6MESTGrowjo estimate

BiVACOR CEO & employees

Jim Dillon is CEO of BiVACOR. BiVACOR has 57 employees (September 2025, LinkedIn).

0
20
40
57
2025
ReportedOne figure per year; a reported figure wins over an estimate

BiVACOR FAQ

What is BiVACOR's revenue?

Growjo estimates BiVACOR's revenue at about $18.6M a year (September 2025). The company hasn't published its own figure.

How many employees does BiVACOR have?

BiVACOR has 57 employees as of September 2025, according to LinkedIn.

Who is the CEO of BiVACOR?

Jim Dillon is the CEO of BiVACOR.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun BiVACOR? Join the podcast